Thyroid hormone actions in liver cancer

Sheng Ming Wu, Wan Li Cheng, Crystal D. Lin, Kwang Huei Lin

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

The thyroid hormone 3,3′,5-triiodo-l-thyronine (T3) mediates several physiological processes, including embryonic development, cellular differentiation, metabolism, and the regulation of cell proliferation. Thyroid hormone receptors (TRs) generally act as heterodimers with the retinoid X receptor (RXR) to regulate target genes. In addition to their developmental and metabolic functions, TRs have been shown to play a tumor suppressor role, suggesting that their aberrant expression can lead to tumor transformation. Conversely, recent reports have shown an association between overexpression of wild-type TRs and tumor metastasis. Signaling crosstalk between T3/TR and other pathways or specific TR coregulators appear to affect tumor development. Since TR actions are complex as well as cell context-, tissue- and time-specific, aberrant expression of the various TR isoforms has different effects during diverse tumorigenesis. Therefore, elucidation of the T 3/TR signaling mechanisms in cancers should facilitate the identification of novel therapeutic targets. This review provides a summary of recent studies focusing on the role of TRs in hepatocellular carcinomas (HCCs).

Original languageEnglish
Pages (from-to)1915-1936
Number of pages22
JournalCellular and Molecular Life Sciences
Volume70
Issue number11
DOIs
Publication statusPublished - Jun 2013
Externally publishedYes

Fingerprint

Thyroid Hormone Receptors
Liver Neoplasms
Thyroid Hormones
Neoplasms
Thyronines
Physiological Phenomena
Retinoid X Receptors
Triiodothyronine
Embryonic Development
Hepatocellular Carcinoma
Protein Isoforms
Carcinogenesis
Cell Proliferation
Neoplasm Metastasis

Keywords

  • Gene regulation
  • Hepatocellular carcinoma
  • Metastasis
  • Thyroid hormone
  • Thyroid hormone receptor
  • Tumor suppressor

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Molecular Medicine
  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Thyroid hormone actions in liver cancer. / Wu, Sheng Ming; Cheng, Wan Li; Lin, Crystal D.; Lin, Kwang Huei.

In: Cellular and Molecular Life Sciences, Vol. 70, No. 11, 06.2013, p. 1915-1936.

Research output: Contribution to journalReview article

Wu, Sheng Ming ; Cheng, Wan Li ; Lin, Crystal D. ; Lin, Kwang Huei. / Thyroid hormone actions in liver cancer. In: Cellular and Molecular Life Sciences. 2013 ; Vol. 70, No. 11. pp. 1915-1936.
@article{b8ef746c32204318874986943f59448f,
title = "Thyroid hormone actions in liver cancer",
abstract = "The thyroid hormone 3,3′,5-triiodo-l-thyronine (T3) mediates several physiological processes, including embryonic development, cellular differentiation, metabolism, and the regulation of cell proliferation. Thyroid hormone receptors (TRs) generally act as heterodimers with the retinoid X receptor (RXR) to regulate target genes. In addition to their developmental and metabolic functions, TRs have been shown to play a tumor suppressor role, suggesting that their aberrant expression can lead to tumor transformation. Conversely, recent reports have shown an association between overexpression of wild-type TRs and tumor metastasis. Signaling crosstalk between T3/TR and other pathways or specific TR coregulators appear to affect tumor development. Since TR actions are complex as well as cell context-, tissue- and time-specific, aberrant expression of the various TR isoforms has different effects during diverse tumorigenesis. Therefore, elucidation of the T 3/TR signaling mechanisms in cancers should facilitate the identification of novel therapeutic targets. This review provides a summary of recent studies focusing on the role of TRs in hepatocellular carcinomas (HCCs).",
keywords = "Gene regulation, Hepatocellular carcinoma, Metastasis, Thyroid hormone, Thyroid hormone receptor, Tumor suppressor",
author = "Wu, {Sheng Ming} and Cheng, {Wan Li} and Lin, {Crystal D.} and Lin, {Kwang Huei}",
year = "2013",
month = "6",
doi = "10.1007/s00018-012-1146-7",
language = "English",
volume = "70",
pages = "1915--1936",
journal = "Cellular and Molecular Life Sciences",
issn = "1420-682X",
publisher = "Birkhauser Verlag Basel",
number = "11",

}

TY - JOUR

T1 - Thyroid hormone actions in liver cancer

AU - Wu, Sheng Ming

AU - Cheng, Wan Li

AU - Lin, Crystal D.

AU - Lin, Kwang Huei

PY - 2013/6

Y1 - 2013/6

N2 - The thyroid hormone 3,3′,5-triiodo-l-thyronine (T3) mediates several physiological processes, including embryonic development, cellular differentiation, metabolism, and the regulation of cell proliferation. Thyroid hormone receptors (TRs) generally act as heterodimers with the retinoid X receptor (RXR) to regulate target genes. In addition to their developmental and metabolic functions, TRs have been shown to play a tumor suppressor role, suggesting that their aberrant expression can lead to tumor transformation. Conversely, recent reports have shown an association between overexpression of wild-type TRs and tumor metastasis. Signaling crosstalk between T3/TR and other pathways or specific TR coregulators appear to affect tumor development. Since TR actions are complex as well as cell context-, tissue- and time-specific, aberrant expression of the various TR isoforms has different effects during diverse tumorigenesis. Therefore, elucidation of the T 3/TR signaling mechanisms in cancers should facilitate the identification of novel therapeutic targets. This review provides a summary of recent studies focusing on the role of TRs in hepatocellular carcinomas (HCCs).

AB - The thyroid hormone 3,3′,5-triiodo-l-thyronine (T3) mediates several physiological processes, including embryonic development, cellular differentiation, metabolism, and the regulation of cell proliferation. Thyroid hormone receptors (TRs) generally act as heterodimers with the retinoid X receptor (RXR) to regulate target genes. In addition to their developmental and metabolic functions, TRs have been shown to play a tumor suppressor role, suggesting that their aberrant expression can lead to tumor transformation. Conversely, recent reports have shown an association between overexpression of wild-type TRs and tumor metastasis. Signaling crosstalk between T3/TR and other pathways or specific TR coregulators appear to affect tumor development. Since TR actions are complex as well as cell context-, tissue- and time-specific, aberrant expression of the various TR isoforms has different effects during diverse tumorigenesis. Therefore, elucidation of the T 3/TR signaling mechanisms in cancers should facilitate the identification of novel therapeutic targets. This review provides a summary of recent studies focusing on the role of TRs in hepatocellular carcinomas (HCCs).

KW - Gene regulation

KW - Hepatocellular carcinoma

KW - Metastasis

KW - Thyroid hormone

KW - Thyroid hormone receptor

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=84878280546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878280546&partnerID=8YFLogxK

U2 - 10.1007/s00018-012-1146-7

DO - 10.1007/s00018-012-1146-7

M3 - Review article

C2 - 22955376

AN - SCOPUS:84878280546

VL - 70

SP - 1915

EP - 1936

JO - Cellular and Molecular Life Sciences

JF - Cellular and Molecular Life Sciences

SN - 1420-682X

IS - 11

ER -